Cedric Burg

Check out AUX-001 Phase 1a results presented at European Society of Cardiology annual meeting in London by Uwe Tigör, MD, our Chief Medical Officer at Auxilius Pharma. Phase 1a study explored the safety, tolerability, and pharmacokinetics of our compound, which is promising new medication for chronic stable angina. Now that the meeting’s embargo has lifted, we’re thrilled to share these results with you! Check out the attached presentation for more details. If you’d like the full version of the deck, feel free to reach out directly to @Uwe Tigör, MD or to me #cardiology #CSAP #AUX001 #ESC #newmedication #biotech #news

43

In #Brussels today to meet with key stakeholders and discuss the importance of ensuring #Europe’s competitiveness to maintain a strong economic base and a flourishing industry.   With the new European commission taking office before the end of the year, it is a crucial time to step up our vision for the future of Europe. Based on the recommendations called upon by the Antwerp Declaration, this new mandate needs to be the one for a “European Industrial Deal”    At Servier, we fully support this call. With the pharmaceutical industry employing over 2.7 million people in Europe and contributing the most to the EU trade surplus with €171 billion in 2022, it is essential to create favorable conditions to attract the talent necessary for the sustainability of our innovative industry.   As we look ahead to the upcoming decisions at the European level, it is key that the EU’s competitiveness remains a priority to ensure a striving innovative ecosystem. Servier remains committed to supporting this effort. 👉 https://lnkd.in/ehawkRYh #EUPharmaLegislation #AntwerpDeclaration #Europe #Industry #Innovation #Patients

696

4 comentarios

NEXT Pharma Summit started about an hour ago..I was already impressed by the quality and by topics covered #NEXT #health #healthcare #conference #commercial #CX #Al #tech #transformation #medicalaffairs #marketing #digital

3

As the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting concludes, we reflect on the innovative discoveries unveiled this year. In a new article, Henar Hevia, Senior Director and EMEA Therapeutic Area Lead for Oncology, goes one step further, delving into the past, present as well as the future of lung cancer care, since the ground-breaking identification of EGFR mutations in lung cancer, and how this has paved the way for improved patient outcomes. Read it here: https://lnkd.in/eH5tTg5G #ASCO24 #PrecisionMedicine #LungCancer #InFrontOfCancer

218

2 comentarios

I’m pleased to share an opinion piece I authored in Euractiv, where, at this critical juncture for the future of health in the EU, I call for urgent action to address two mutually supportive goals: future-proofing European health systems and ensuring the long-term competitiveness of the EU’s life sciences sector. Have a read and let me know your views: https://bit.ly/4aE6k8n. #JourneyToBetterHealthcare  

87

2 comentarios

Final day of #ESMO24 and Dean McAlister summarises eloquently through an American football analogy how we at #Inizio can help. Pop by and visit the team to understand more - we're a friendly bunch. ➡️ Booth 431e #oncology #cancer #healthcare #science #innovation #patientoutcomes #medicalaffairs #biopharma #lifesciences #reimaginehealth

12